Daniel F. Gibbard, Rebecca E. Schmitt, Andrew J. Hennigan, Aneesha Dasgupta, Jessica Z. Schneider, Jason D. Doles
{"title":"Mitochondrial Pathway Dysregulation Defines Regenerative Failure in Volumetric Muscle Loss","authors":"Daniel F. Gibbard, Rebecca E. Schmitt, Andrew J. Hennigan, Aneesha Dasgupta, Jessica Z. Schneider, Jason D. Doles","doi":"10.1002/rco2.70054","DOIUrl":"https://doi.org/10.1002/rco2.70054","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Volumetric muscle loss (VML) is a major muscle injury that significantly impacts quality of life in affected individuals. This substantial loss of muscle tissue leads to various complications including reduced force output, impaired muscle regeneration and long-term mobility issues. Although skeletal muscle is typically a highly regenerative tissue, damage beyond a critical threshold prevents full recovery. To better understand this limitation, we investigated the differences between more regenerative (healing) and less regenerative (nonhealing) muscle in a murine model of VML.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We used longitudinal strength measurements, transcriptomic analyses and bioinformatics to assess differences between injury (defect) sizes. These approaches were used to assess functional recovery and to identify molecular and metabolic features associated with healing versus nonhealing injuries.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Our results showed that 2-mm VML defects led to reduced force outputs at 7 and 14 days of postinjury but recovered to baseline levels by 28 days—indicating healing. In contrast, mice with 4-mm VML injuries failed to recover force output by 28 days—representing a nonhealing response. Transcriptomic and bioinformatic analyses revealed that nonhealing injuries exhibited prolonged activation of healing-associated pathways. Mitochondria-related transcript signatures were most strongly correlated with both strength loss and defect size. Additionally, we observed metabolic alterations at the whole muscle level via a shift in myofiber isotype composition—specifically a reduction in fast, glycolytic type IIB myofibers and an increase in oxidative type IIA myofibers.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>These findings highlight the critical role of mitochondrial function and metabolic rewiring in determining regenerative outcomes following VML injury. Differences in mitochondrial activity, protein expression and myofiber composition distinguish healing from nonhealing defects and may explain why larger injuries fail to fully recover.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73544,"journal":{"name":"JCSM rapid communications","volume":"9 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/rco2.70054","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149356044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Muscle Ultrasound: A Narrative Review of Methodology and Relationships Between Muscle Ultrasound Thickness and Other Measures of Muscle Mass","authors":"Lian H. Cerella, Jane Ziegler, Garth S. Nanni","doi":"10.1002/rco2.70049","DOIUrl":"https://doi.org/10.1002/rco2.70049","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The lack of muscle ultrasound training and resources tailored to registered dietitian nutritionists (RDNs) has been a barrier to its clinical use. To better understand the clinical applicability of muscle ultrasound measurements, the primary aim of this narrative review was to identify and evaluate primary research studies assessing the relationship between ultrasound-derived muscle thickness measures and other accepted measures of muscle mass. A secondary aim was to address the educational gap by providing a comprehensive summary of muscle ultrasound methodologies that can be used by RDNs in practice.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A review of the literature was completed in March 2026 using PubMed, SCOPUS, CINAHL and EMBASE. Studies were included from any year and if they were available in English. Articles were excluded if participants were less than 18 years old or included non-human subjects. We reviewed studies using a systematic approach, looking for studies that examined the relationship between an ultrasound-derived muscle thickness measure and another measure of muscle mass. We applied recommendations from the Academy of Nutrition and Dietetics' Evidence Analysis Process to evaluate methodological quality. Findings were synthesized using a narrative approach, with comparisons based on common findings across muscle sites. When <i>p</i> values for Pearson's or Spearman's rank correlation tests were missing, we contacted the corresponding authors for additional information.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>This narrative review included 25 primary research studies. Limited studies were available that evaluated the relationship between ultrasound-derived temporalis, masseter, biceps, triceps, psoas and gastrocnemius muscle thickness measures and another measure of muscle mass. This review found that ultrasound-derived quadriceps muscle thickness measures typically had a moderate, direct correlation with other body composition assessment measures. Muscle ultrasound methodologies were identified and detailed for eight muscle groups: temporalis, masseter, biceps, triceps, abdominal, psoas, quadriceps and gastrocnemius muscles.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>We found that quadriceps muscle thickness typically had a moderate significant association with other measures of muscle mass. More research is needed to determine how ultrasound-derived muscle mass measures can be applied in clinical practice. This review helps to address the gap in education for dietitian","PeriodicalId":73544,"journal":{"name":"JCSM rapid communications","volume":"9 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/rco2.70049","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149258957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Bimagrumab in Muscle Wasting and Obesity","authors":"Stephan von Haehling","doi":"10.1002/rco2.70053","DOIUrl":"https://doi.org/10.1002/rco2.70053","url":null,"abstract":"<p>In 1997, a landmark paper was published when Alexandra McPherron and colleagues at the Johns Hopkins University identified a new member of the transforming growth factor-β family that they initially called growth/differentiation factor 8 (GDF-8) [<span>1</span>]. When they deleted the GDF-8 gene in mice, the animals developed a striking, widespread increase in skeletal muscle with individual muscles weighing 2–3 times more than those of normal mice, owing to both larger and a greater number of muscle fibres. Hence, GDF-8, whose gene is expressed almost exclusively in skeletal muscle, appeared to be a powerful negative regulator of muscle growth—a natural brake that prevents excessive muscle development. It was therefore a logical step for the protein to become better known as myostatin—literally a factor that restrains muscle growth [<span>2, 3</span>] Only some months after the first description in <i>Nature</i>, two independent groups showed that naturally occurring mutations in the same gene caused the long-recognised ‘double-muscling’ phenotype in Belgian Blue and Piedmontese cattle that already attracted considerable attention from beef producers years ago. Blue cattle breed segregation analysis suggested an autosomal recessive inheritance. Thus, an experimental finding in genetically modified mice immediately explained a naturally occurring animal phenotype. Compelling evidence that the same system also operates in humans came in 2004, when Schuelke and colleagues described a child with extraordinary muscle development caused by a loss-of-function mutation in the myostatin gene [<span>4</span>].</p><p>These discoveries suggested an apparently straightforward therapeutic strategy. If the loss of myostatin produced more muscle, then pharmacologically blocking myostatin might reproduce at least part of this effect in patients with muscle wasting. In simple terms, the idea was to put a brake on the biological brake—or, more accurately, to release the brake on muscle growth. The next question was where in the signalling pathway this intervention should occur. Myostatin exerts its effects by binding to activin type II receptors on the surface of muscle cells, particularly ActRIIB and, to a lesser extent, ActRIIA. Blocking myostatin itself was one possibility; blocking the receptor through which its message was transmitted offered another. Indeed, a decisive advance came in 2005, when Se-Jin Lee and colleagues administered a soluble form of ActRIIB to mice [<span>5</span>]. This engineered receptor circulated outside the cells and acted as a ligand trap: Instead of allowing myostatin to bind to receptors on muscle cells, it captured the protein before its inhibitory signal could be delivered (Figure 1). Within only 2 weeks, treated wild-type mice gained up to 60% in muscle mass. Even more importantly, the effect was reduced but not abolished in mice that were genetically unable to produce myostatin. Myostatin could therefore not be the only mol","PeriodicalId":73544,"journal":{"name":"JCSM rapid communications","volume":"9 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/rco2.70053","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149258235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neetika Bharaj, Sarkis J. Hannaian, José A. Correa, Mariana De Sa Tavares Russo, Daina Avizonis, Todd A. Duhamel, Rakesh C. Arora, Emmanuel Moss, Jonathan Afilalo, Tyler A. Churchward-Venne
{"title":"D3-Creatine Derived Skeletal Muscle Mass Correlates With Grip Strength in (Pre)frail Older Adult Patients Undergoing Cardiac Surgery","authors":"Neetika Bharaj, Sarkis J. Hannaian, José A. Correa, Mariana De Sa Tavares Russo, Daina Avizonis, Todd A. Duhamel, Rakesh C. Arora, Emmanuel Moss, Jonathan Afilalo, Tyler A. Churchward-Venne","doi":"10.1002/rco2.70050","DOIUrl":"https://doi.org/10.1002/rco2.70050","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>(Pre)frail older adult patients undergoing cardiac surgery experience disproportionate mortality and prolonged length of stay, underpinned by low skeletal muscle mass (SMM), which is central to the underlying frailty pathophysiology. Conventional methods for assessing SMM have well-recognized limitations in this population. The D<sub>3</sub>-creatine (D<sub>3</sub>-Cr) dilution method offers a non-invasive, direct estimate of total-body SMM. Pre-surgery D<sub>3</sub>-Cr derived SMM and its relationship with strength, physical performance and multidimensional health status measures in (pre)frail older adult patients undergoing cardiac surgery have not been explored.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Seventeen (pre)frail older adult patients (16 male, 1 female; median 75 [interquartile range: 67–75] years; body mass index 28.7 [24.2–29.9] kg/m<sup>2</sup>; Clinical Frailty Scale 3 [3, 4]) ingested a single 30-mg oral dose of D<sub>3</sub>-Cr 3.5 [3.0–4.3] days prior to scheduled elective or non-emergent (inpatient) cardiac surgery. Spot urine was collected pre-dose and 48–72 h post-dose, and D<sub>3</sub>-creatinine (D<sub>3</sub>-Crn) and unlabelled creatine and creatinine were quantified by liquid chromatography–tandem mass spectrometry. Total-body SMM was estimated using a published spillage-correction algorithm; both a height-adjusted and body weight–adjusted SMM index were calculated as SMM divided by height squared and SMM divided by body weight. Spearman's rank correlations (r<sub>s</sub>) between strength, physical performance outcomes and multidimensional health status measures and (i) absolute SMM, (ii) height-adjusted SMM index and (iii) body weight–adjusted SMM index were calculated; bias-corrected and accelerated bootstrap (10 000 resamples) provided 95% confidence intervals (CIs). Kendall's τ was also calculated as a sensitivity analysis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Median absolute total-body SMM derived from D<sub>3</sub>-Cr dilution was 31.7 [27.4–40.9] kg, and the corresponding height-adjusted and body weight–adjusted SMM index was 10.8 [9.7–13.7] and 41.7 [36.1–47.4]. Handgrip strength positively associated with absolute SMM, <i>r</i><sub>s</sub> = 0.61 (95% CI [0.12, 0.91], <i>n</i> = 14, <i>p</i> = 0.02) and height-adjusted SMM index, r<sub>s</sub> = 0.55 (95% CI [0.03, 0.88], <i>n</i> = 14, <i>p</i> = 0.04), but not body weight–adjusted SMM index. The 5× sit-to-stand, 4-m gait speed, balance, Short Physical Performance Battery score, length of stay, SF-36 physical functioning score and Mini Nutritional Assessment score were not significantly associated with abs","PeriodicalId":73544,"journal":{"name":"JCSM rapid communications","volume":"9 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/rco2.70050","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149258045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Claudia Contreras, Diana Paola Córdoba-Rodríguez, Robinson Cuadros, José Ricardo Jauregui, Ángel Labán Castro Castro, Diana Trejos-Gallego, Fernando Pereira, Susan Martínez, Linda Ibatá, Julieth Carolina Castillo
{"title":"Expert Consensus on Diagnosis and Management of Secondary Sarcopenia in Adults in Colombia: A Modified Delphi Study","authors":"Claudia Contreras, Diana Paola Córdoba-Rodríguez, Robinson Cuadros, José Ricardo Jauregui, Ángel Labán Castro Castro, Diana Trejos-Gallego, Fernando Pereira, Susan Martínez, Linda Ibatá, Julieth Carolina Castillo","doi":"10.1002/rco2.70051","DOIUrl":"https://doi.org/10.1002/rco2.70051","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Secondary sarcopenia driven by chronic disease, acute illness, immobilization, malnutrition or treatment-related factors contributes to functional decline, falls, disability, readmission and mortality. In Colombia, uneven access to body composition assessment, nutrition services and rehabilitation limits timely recognition and management.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a modified Delphi expert consensus to develop Colombia-focused recommendations for adults with suspected or confirmed secondary sarcopenia. Seven invited experts from geriatrics, intensive care medicine, clinical nutrition, physiotherapy, rehabilitation and surgery accepted participation and completed the consensus process. A structured evidence review from 2015 to 2025 informed 90 candidate statements across screening, diagnosis, nutrition, therapeutic exercise and follow-up. Statements were rated using a 5-point Likert scale. For each statement, a weighted consensus score was calculated as the sum of Likert scores divided by the maximum possible score and multiplied by 100. A weighted score of 70% or higher was prespecified as the approval threshold.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The 90 candidate statements were reduced to 50 final recommendations, representing a net reduction of 40 statements. The recommendations were organized into six thematic tables and address screening triggers, stepwise diagnostic confirmation, early interdisciplinary management, individualized nutrition strategies, structured multicomponent exercise and longitudinal reassessment using consistent baseline measures.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>This evidence-informed expert consensus provides practical recommendations for screening, diagnosis, treatment and follow-up of secondary sarcopenia in adults in Colombia. The document is intended as expert consensus guidance rather than a formal clinical practice guideline. Selected elements may be relevant to settings with similar access constraints, but external validation is required.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73544,"journal":{"name":"JCSM rapid communications","volume":"9 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/rco2.70051","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149206036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Possible Association of Elevated Delta-Like Protein 4 Concentration With Low Walking Speed and Low Handgrip Strength in Japanese Older Adults","authors":"Keisuke Endo, Kei Nakata, Tatsuya Sato, Marenao Tanaka, Erika Ishiwata, Yukinori Akiyama, Wataru Kawaharata, Hiroki Aida, Masayuki Koyama, Hirofumi Ohnishi, Masato Furuhashi","doi":"10.1002/rco2.70052","DOIUrl":"https://doi.org/10.1002/rco2.70052","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>A recent study using mice showed that delta-like protein 4 (Dll4), a ligand released from the impaired vascular endothelium, can activate Notch receptor 2 signals in skeletal muscles, leading to muscle atrophy and dysfunction. However, it remains unclear whether circulating Dll4 is associated with ageing-related physical dysfunction in humans and sarcopenia diagnosed by both low muscle mass and low muscle strength.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We investigated the associations of serum Dll4 level as the main outcome with physical performance, muscle strength and muscle mass in 283 Japanese older adults defined as ≥ 65 years of age (men/women: 125/158, mean age: 75 ± 6 years) who received annual health checkups in the Tanno–Sobetsu Study, a population-based cohort.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Dll4 concentration was negatively correlated with levels of high-density lipoprotein cholesterol (HDL-C) (<i>r</i> = −0.17, <i>p</i> = 0.01) and fasting glucose (<i>r</i> = −0.12, <i>p</i> = 0.048) and with walking speed (<i>r</i> = −0.14, <i>p</i> = 0.02) but not with handgrip strength (<i>r</i> = −0.04, <i>p</i> = 0.47) or appendicular skeletal muscle mass index (ASMI) (<i>r</i> = 0.01, <i>p</i> = 0.85). When subjects were divided by sex, Dll4 level was inversely correlated with walking speed (<i>r</i> = −0.17, <i>p</i> = 0.03) and handgrip strength (<i>r</i> = −0.17, <i>p</i> = 0.04) in women but not in men. Multivariable regression analysis after adjustment of age, sex, body mass index and levels of HDL-C and fasting glucose showed that walking speed (β = −0.15, <i>p</i> = 0.04) or handgrip strength (β = −0.24, <i>p</i> = 0.03) was independently associated with Dll4 level. Conversely, Dll4 level was independently associated with walking speed (β = −0.12, <i>p</i> = 0.03) or handgrip strength (β = −0.09, <i>p</i> = 0.03) but not ASMI (β = 0.06, <i>p</i> = 0.22) after adjustment of age, sex and body mass index as consistent confounders in exploratory analyses. There was no significant interaction between sex and Dll4 level for walking speed and handgrip strength. Furthermore, the addition of Dll4 level into the consistent confounders significantly improved discriminatory capacity for predicting low walking speed, but not low handgrip strength and low ASMI, in the integrated discrimination improvement and continuous net reclassification improvement.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>A high serum level of Dll4 is independently associated with low walking speed and low musc","PeriodicalId":73544,"journal":{"name":"JCSM rapid communications","volume":"9 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/rco2.70052","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149145992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Myopenia in HFpEF: Impaired Muscle Quality Beyond the Heart","authors":"Alessandro Pocai","doi":"10.1002/rco2.70048","DOIUrl":"https://doi.org/10.1002/rco2.70048","url":null,"abstract":"<p>Heart failure with preserved ejection fraction (HFpEF) is increasingly understood as a systemic disorder of impaired energetics and metabolic inflammation rather than an isolated disease of cardiac structure or haemodynamics. Although cardiac abnormalities define the diagnosis, they do not explain the severity of exercise intolerance, fatigue and loss of physical function that dominate the clinical phenotype. Converging physiological, metabolic and clinical evidence identifies extracardiac mechanisms, particularly skeletal muscle dysfunction, as key determinants of disability in HFpEF. Recent studies have reported an association between expansion of epicardial adipose tissue (EAT) and skeletal muscle fatigability in HFpEF, independent of generalized obesity or body mass index. Strikingly, muscle endurance is disproportionately impaired relative to muscle mass or maximal strength, revealing a qualitative defect in muscle performance rather than classical sarcopenia. This dissociation, illustrated by preserved force generation alongside accelerated fatigue, implicates impaired mitochondrial oxidative capacity and reduced fatigue resistance as central contributors to functional limitation. In this review, we synthesize emerging evidence on skeletal muscle bioenergetics, mitochondrial dysfunction and adipose–muscle crosstalk to propose a myopenic phenotype as a unifying framework for HFpEF-related disability. Myopenia, defined as clinically meaningful muscle dysfunction driven primarily by impaired muscle quality rather than overt muscle wasting, captures a pattern of wasting biology without obligatory loss of muscle mass. Within this framework, EAT is conceptualized as a metabolically active visceral fat depot that may amplify systemic inflammation and disrupt skeletal muscle oxidative metabolism through an integrated adipo-muscular axis. By shifting emphasis from cardiac mechanics and muscle quantity towards muscle endurance, metabolic efficiency and inter-organ energetic signalling, this framework aligns HFpEF with systems-level paradigms underlying cachexia, metabolic ageing and chronic organ failure. Framing HFpEF as a clinically relevant myopenic state supports muscle-centric outcome measures and integrated therapeutic strategies aimed at correcting multisystem energetic failure and preventing loss of physical function.</p>","PeriodicalId":73544,"journal":{"name":"JCSM rapid communications","volume":"9 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/rco2.70048","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149048166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Christopher Hurst, Jonas Johansson, Miles D. Witham, Sian M. Robinson, Rachel Cooper, Avan A. Sayer
{"title":"Resistance Exercise Training for Skeletal Muscle Health in Adults Living With Multiple Long-Term Conditions: A Scoping Review","authors":"Christopher Hurst, Jonas Johansson, Miles D. Witham, Sian M. Robinson, Rachel Cooper, Avan A. Sayer","doi":"10.1002/rco2.70045","DOIUrl":"https://doi.org/10.1002/rco2.70045","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Low muscle strength is prevalent in individuals living with multiple long-term conditions (MLTC). Resistance exercise (RE) training is the most effective treatment for improving strength and physical performance across the life course, but little is known about RE in people living with MLTC. This scoping review aimed to identify published evidence on RE as a treatment for improving muscle mass, strength and physical performance in adults living with MLTC.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Six electronic databases were searched to identify studies published up to May 2025 that included adults aged ≥ 18 years who were living with two or more long-term conditions and undertaking a RE intervention.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Sixty-eight papers representing 66 unique studies met the inclusion criteria. A range of methods for characterising MLTC were reported; almost half of the papers (30/68) that included people living with ≥ 2 LTC focused on comorbidity (i.e., participants selected based on the presence of an index condition plus one or more coexisting conditions). There were only seven papers that specifically described their population as living with MLTC. Importantly, only 11 of the included studies involved interventions that were RE only with most including RE performed as part of a multicomponent exercise programme (RE-MCT). None of the RE interventions reported increases in muscle mass, although improvements in muscle strength were observed in four of seven papers and physical performance in five of eight papers. In studies involving RE-MCT, one paper reported a postintervention increase in muscle mass, whereas muscle strength improved in 44% (12/27) of papers where it was measured. Improvements in physical performance were reported across most RE-MCT studies (85%). Exercise session attendance was generally good with few reported adverse events across both RE and RE-MCT interventions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>RE training may be effective for improving strength and physical performance in adults living with MLTC. However, only a small number of studies have evaluated the effects of RE alone in this population, with RE typically incorporated within a broader multicomponent exercise programme. Consequently, more research is needed to understand the effects of interventions, which involve RE alone, but also in comparison with RE-MCT programmes, in individuals living with MLTC across the adult life course.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73544,"journal":{"name":"JCSM rapid communications","volume":"9 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/rco2.70045","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148848632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gregory L. Maas, Marcus P. Mullen, Brooke D. Shepard, Jack F. Gugel, Dakota R. Hunt, Virginia Ferguson, Sarah Calve, Thomas G. Martin, Leslie A. Leinwand
{"title":"Fibre Type and Stimulus Determine Progression of Skeletal Muscle Atrophy","authors":"Gregory L. Maas, Marcus P. Mullen, Brooke D. Shepard, Jack F. Gugel, Dakota R. Hunt, Virginia Ferguson, Sarah Calve, Thomas G. Martin, Leslie A. Leinwand","doi":"10.1002/rco2.70047","DOIUrl":"https://doi.org/10.1002/rco2.70047","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Skeletal muscle atrophy is prevalent worldwide and is a major detractor from length and quality of life. It is often diagnosed and treated as a single disorder, but the causal stimuli and progression of atrophy vary widely. Malnutrition and disuse are two common causes of muscle atrophy, and despite their prevalence and extensive characterization, there have been no direct comparisons of how these two types of atrophy progress and whether they differentially affect skeletal muscle fibre types. The purpose of this study is to directly compare atrophy from starvation and disuse and provide a transcriptomic resource for future research.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Twelve-week-old female C57BL/6 mice were starved for 3 days to induce malnutrition atrophy or were hindlimb suspended (HS) for 3, 7, 14 or 28 days to induce disuse atrophy. At each timepoint, three muscles (tibialis anterior [TA], extensor digitorum longus [EDL] and soleus) were collected, weighed, sectioned and stained, and RNA was extracted for transcriptomic analysis. Atrophy progression and gene expression changes were compared across muscle fibre types and atrophy stimuli.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>We found differences in atrophy progression between muscle fibre types based on fibre twitch speed and atrophy stimulus. Starved mice lost 25% total body weight, 18% fast-twitch TA mass and 6% TA fibre cross sectional area (CSA), 21% EDL mass and 10% CSA, and 12% soleus mass and 3% CSA. In contrast, 7-day HS mice lost 18% slow-twitch soleus, 8% TA mass and 2% EDL mass. The soleus mass loss progressed to ~40% by 14 and 28 days of HS with 20% CSA loss. Gene expression varied across both atrophy stimuli. In starvation, 3618 and 2556 genes were significantly differentially expressed in the EDL and soleus, respectively. With HS, expression of 312 was altered in the EDL and 1072 in the soleus. Gene set enrichment analysis identified increased abundance of aerobic respiration genes in the EDL versus soleus with starvation and increased amino acid metabolism gene expression in the unloaded soleus versus EDL.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Atrophy progression varies based on stimuli and muscle fibre type. This study provides a large, matched data set where the effects of different atrophic stimuli can be easily and directly compared in multiple fibre types. This work demonstrates that atrophy is not a single disorder at the molecular scale and suggests that therapeutic development may need to be tailored t","PeriodicalId":73544,"journal":{"name":"JCSM rapid communications","volume":"9 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/rco2.70047","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148848633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marjola Thanaj, Brandon Whitcher, Hamzah Raza, Camilo Bradford-Bell, Marili Niglas, Jimmy D. Bell, Dimitri Amiras, E. Louise Thomas
{"title":"Gluteus Maximus Shape Reveals Sex-Specific Associations Between Morphology and Metabolic Dysfunction","authors":"Marjola Thanaj, Brandon Whitcher, Hamzah Raza, Camilo Bradford-Bell, Marili Niglas, Jimmy D. Bell, Dimitri Amiras, E. Louise Thomas","doi":"10.1002/rco2.70046","DOIUrl":"https://doi.org/10.1002/rco2.70046","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The gluteus maximus (GM) is a major hip extensor essential for mobility and metabolic health. Previous studies rely on global measures, such as muscle volume or fat fraction, which can overlook spatially localised differences in shape across the GM. Here, we integrate conventional volumetric and fat fraction metrics with 3D mesh-based shape phenotypes to provide a spatially resolved characterisation of GM morphology in relation to anthropometric, lifestyle and cardiometabolic factors, with a focus on type 2 diabetes (T2D) and sex-specific effects.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We analysed T1 Dixon MRI from UK Biobank participants to quantify GM muscle volume, fat fraction and regional surface morphology using 3D meshes. Statistical parametric mapping was used to assess regional associations with anthropometric, lifestyle and clinical variables. Statistical shape analysis was used to derive principal components (PCs) summarising major modes of GM shape variation, which were evaluated for associations with disease outcomes. Bidirectional causal mediation analyses were performed using GM volumetric and PCs of shape variation. Longitudinal changes in GM composition were assessed in participants with repeat imaging.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>GM muscle volume and fat fraction were strongly associated with age, adiposity and physical activity. Shape analysis identified spatially localised remodelling patterns that were not captured by global measures, revealing region-specific surface shrinkage linked to age, BMI, alcohol intake, grip strength, physical activity, frailty, osteoporosis and cardiometabolic disease. T2D exhibited distinct sex-specific patterns: Men showed predominantly inward deformation across the anterior and central GM, whereas women demonstrated outward deformation in corresponding anterior regions and throughout the posterior muscle, with several posterior regions significant only in women. Mediation analyses suggested that T2D-related changes in GM morphology partly mediated increases in fat fraction, indicating that diabetes influences regional muscle shape beyond overall muscle size. PCs representing variation in the central-superior posterior and anterior GM differentiated T2D cases from controls and were associated with incident T2D risk (men: left GM PC6 HR per SD 0.81 [0.70–0.95], false discovery rate [FDR]-adjusted <i>p</i> = 0.038; right GM PC6 HR 0.76 [0.65–0.88], <i>p</i> = 0.002; women: right GM PC5 HR 1.32 [1.08–1.61], <i>p</i> = 0.032).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions<","PeriodicalId":73544,"journal":{"name":"JCSM rapid communications","volume":"9 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/rco2.70046","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148696261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}